Cleavage of Kininogen and subsequent Bradykinin release by the complement component: Mannose-binding lectin-associated serine protease (MASP)-1

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Dobó, József ^a   Major, Balázs ^a   Kékesi, Katalin A ^b   Szabó, István ^a   Megyeri, Márton ^a   Hajela, Krishnan ^c   Juhász, Gábor ^b   Závodszky, Péter ^a   Gál, Péter ^a  

^a INSTITUTE OF ENZYMOLOGY   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c DEVI AHILYA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 1; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; PREKALLIKREIN; SERINE PROTEINASE; UNCLASSIFIED DRUG; KININOGEN; MASP1 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ANGIONEUROTIC EDEMA; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; FUNCTIONAL PROTEOMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SECRETION; ELECTROSPRAY MASS SPECTROMETRY; HYDROLYSIS; METABOLISM;

BRADYKININ; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; HYDROLYSIS; KININOGENS; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 79956367712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020036     Document Type: Article

References (42)

1. Kaplan AP, Joseph K, Silverberg M, (2002) Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol 109: 195-209.
2. Kaplan AP, Ghebrehiwet B, (2010) The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol 47: 2161-2169.
3. Oehmcke S, Herwald H, (2010) Contact system activation in severe infectious diseases. J Mol Med 88: 121-126.
4. Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M, (2009) C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 15: 69-78.
5. Davis AE 3rd, (2005) The pathophysiology of hereditary angioedema. Clin Immunol 114: 3-9.
6. Kaplan AP, (2010) Enzymatic pathways in the pathogenesis of hereditary angioedema: The role of C1 inhibitor therapy. J Allergy Clin Immunol 126: 918-925.
7. Joseph K, Tholanikunnel BG, Kaplan AP, (2009) Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor. J Allergy Clin Immunol 124: 143-149.
8. Joseph K, Ghebrehiwet B, Peerschke EI, Reid KB, Kaplan AP, (1996) Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R). Proc Natl Acad Sci U S A 93: 8552-8557.
9. Ricklin D, Hajishengallis G, Yang K, Lambris JD, (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797.
10. Dunkelberger JR, Song WC, (2010) Complement and its role in innate and adaptive immune responses. Cell Res 20: 34-50.
11. Gál P, Dobó J, Závodszky P, Sim RB, (2009) Early complement proteases: C1r, C1s and MASPs. A structural insight into activation and functions. Mol Immunol 46: 2745-2752.
12. Krarup A, Gulla KC, Gál P, Hajela K, Sim RB, (2008) The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen. Biochim Biophys Acta 1784: 1294-1300.
13. Megyeri M, Makó V, Beinrohr L, Doleschall Z, Prohászka Z, et al. (2009) Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function. J Immunol 183: 3409-3416.
14. Gulla KC, Gupta K, Krarup A, Gál P, Schwaeble WJ, et al. (2010) Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology 129: 482-495.
15. Takahashi K, Chang WC, Takahashi M, Pavlov V, Ishida Y, et al. (2011) Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation. Immunobiology 216: 96-102.
16. Dobó J, Harmat V, Beinrohr L, Sebestyén E, Závodszky P, et al. (2009) MASP-1, a Promiscuous Complement Protease: Structure of Its Catalytic Region Reveals the Basis of Its Broad Specificity. J Immunol 183: 1207-1214.
17. Kerr FK, Thomas AR, Wijeyewickrema LC, Whisstock JC, Boyd SE, et al. (2008) Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor. Mol Immunol 45: 670-677.
18. Ambrus G, Gál P, Kojima M, Szilágyi K, Balczer J, et al. (2003) Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and-2: A study on recombinant catalytic fragments. J Immunol 170: 1374-1382.
19. Dobó J, Harmat V, Sebestyén E, Beinrohr L, Závodszky P, et al. (2008) Purification, crystallization and preliminary X-ray analysis of human mannose-binding lectin-associated serine protease-1 (MASP-1) catalytic region. Acta Crystallogr F 64: 781-784.
20. Perkins SJ, Smith KF, Amatayakul S, Ashford D, Rademacher TW, et al. (1990) Two-domain structure of the native and reactive centre cleaved forms of C1 inhibitor of human complement by neutron scattering. J Mol Biol 214: 751-763.
21. Santos-González M, Gómez Díaz C, Navas P, Villalba JM, (2007) Modifications of plasma proteome in long-lived rats fed on a coenzyme Q10-supplemented diet. Exp Gerontol 42: 798-806.
22. Szego{double acute} ÉM, Janáky T, Szabó Z, Csorba A, Kompagne H, et al. (2010) A mouse model of anxiety molecularly characterized by altered protein networks in the brain proteome. Eur Neuropsychopharm 20: 96-111.
23. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
24. Tan SM, Chung MC, Kon OL, Thiel S, Lee SH, et al. (1996) Improvements on the purification of mannan-binding lectin and demonstration of its Ca2+-independent association with a C1s-like serine protease. Biochem J 319: 329-332.
25. Schiffman S, Mannhalter C, Tyner KD, (1980) Human high molecular weight kininogen. Effects of cleavage by kallikrein on protein structure and procoagulant activity. J Biol Chem 255: 6433-6438.
26. Mori K, Nagasawa S, (1981) Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein. J Biochem 89: 1465-1473.
27. Tayeh MA, Olson ST, Shore JD, (1994) Surface-induced alterations in the kinetic pathway for cleavage of human high molecular weight kininogen by plasma kallikrein. J Biol Chem 269: 16318-16325.
28. Kocsis A, Kékesi KA, Szász R, Végh BM, Balczer J, et al. (2010) Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and-2: significant contribution of MASP-1 to lectin pathway activation. J Immunol 185: 4169-4178.
29. Nartikova VF, Egorova TP, Rets EV, Paskhina TS, (1986) Various properties and kinetics of interaction of high and low molecular weight human kininogens with human plasma kallikrein. Biokhimiia 1986 51: 463-471.
30. Tans G, Rosing J, Berrettini M, Lämmle B, Griffin JH, (1987) Autoactivation of human plasma prekallikrein. J Biol Chem 262: 11308-11314.
31. Joseph K, Tholanikunnel BG, Kaplan AP, (2002) Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII. Proc Natl Acad Sci U S A 99: 896-900.
32. Terai I, Kobayashi K, Matsushita M, Fujita T, (1997) Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of levels in body fluids and identification of two forms in serum. Clin Exp Immunol 110: 317-323.
33. Møller-Kristensen M, Jensenius JC, Jensen L, Thielens N, Rossi V, et al. (2003) Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J Immunol Methods 282: 159-167.
34. Takahashi M, Iwaki D, Kanno K, Ishida Y, Xiong J, et al. (2008) Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J Immunol 180: 6132-6138.
35. Møller-Kristensen M, Thiel S, Sjöholm A, Matsushita M, Jensenius JC, (2007) Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Int Immunol 19: 141-149.
36. Tang J, Yu CL, Williams SR, Springman E, Jeffery D, et al. (2005) Expression, crystallization, and three-dimensional structure of the catalytic domain of human plasma kallikrein. J Biol Chem 280: 41077-41089.
37. Montalto MC, Collard CD, Buras JA, Reenstra WR, McClaine R, et al. (2001) A keratin peptide inhibits mannose-binding lectin. J Immunol 166: 4148-4153.
38. Wong NK, Kojima M, Dobó J, Ambrus G, Sim RB, (1999) Activities of the MBL-associated serine proteases (MASPs) and their regulation by natural inhibitors. Mol Immunol 36: 853-861.
39. Beinrohr L, Dobó J, Závodszky P, Gál P, (2008) C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation. Trends Mol Med 14: 511-21.
40. Kelemen Z, Moldovan D, Mihály E, Visy B, Széplaki G, et al. (2010) Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema. Clin Immunol 134: 354-358.
41. Varga L, Széplaki G, Laki J, Kocsis A, Kristóf K, et al. (2008) Depressed activation of the lectin pathway of complement in hereditary angioedema. Clin Exp Immunol 153: 68-74.
42. Joseph K, Tuscano TB, Kaplan AP, (2008) Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol 101: 279-286.